Literature DB >> 18211724

Invasive pneumococcal and meningococcal disease: association with influenza virus and respiratory syncytial virus activity?

A G S C Jansen1, E A M Sanders, A VAN DER Ende, A M VAN Loon, A W Hoes, E Hak.   

Abstract

Few studies have examined the relationship between viral activity and bacterial invasive disease, considering both influenza virus and respiratory syncytial virus (RSV). This study aimed to assess the potential relationship between invasive pneumococcal disease (IPD), meningococcal disease (MD), and influenza virus and RSV activity in The Netherlands. Correlations were determined between population-based data on IPD and MD during 1997-2003 and influenza virus and RSV surveillance data. Incidence rate ratios of disease during periods of high influenza virus and RSV activity over the peri-seasonal and summer baseline periods were calculated. The analyses comprised 7266 and 3072 cases of IPD and MD. When data from all seasons were included, the occurrence of pneumococcal bacteraemia and MD correlated significantly with influenza virus and RSV activity both in children and adults. Periods of increased influenza virus and RSV activity showed higher rates of pneumococcal bacteraemia in older children and adults than the peri-season period. Rates of MD in children were also higher during periods of increased influenza virus activity; the same appeared true for MD in older children during periods of increased RSV activity. Although no causal relationship may be inferred from these data, they support a role for influenza virus and RSV in the pathogenesis of IPD and MD.

Entities:  

Mesh:

Year:  2008        PMID: 18211724      PMCID: PMC2870742          DOI: 10.1017/S0950268807000271

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   2.451


  21 in total

1.  Respiratory syncytial virus infection and invasive meningococcal disease: is there an association?

Authors:  Martin C J Kneyber; Adrianus J van Vught
Journal:  Eur J Pediatr       Date:  2003-03-06       Impact factor: 3.183

2.  A 20-year ecological study of the temporal association between influenza and meningococcal disease.

Authors:  Elise Snitker Jensen; Søren Lundbye-Christensen; Susanne Samuelsson; Henrik Toft Sørensen; Henrik Carl Schønheyder
Journal:  Eur J Epidemiol       Date:  2004       Impact factor: 8.082

Review 3.  Respiratory viral infection predisposing for bacterial disease: a concise review.

Authors:  J M Hament; J L Kimpen; A Fleer; T F Wolfs
Journal:  FEMS Immunol Med Microbiol       Date:  1999-12

4.  Influenza A and meningococcal disease.

Authors:  K A Cartwright; D M Jones; A J Smith; J M Stuart; E B Kaczmarski; S R Palmer
Journal:  Lancet       Date:  1991-08-31       Impact factor: 79.321

5.  A simultaneous outbreak of meningococcal and influenza infections.

Authors:  L S Young; F M LaForce; J J Head; J C Feeley; J V Bennett
Journal:  N Engl J Med       Date:  1972-07-06       Impact factor: 91.245

6.  Severe pneumococcal pneumonia in previously healthy children: the role of preceding influenza infection.

Authors:  K L O'Brien; M I Walters; J Sellman; P Quinlisk; H Regnery; B Schwartz; S F Dowell
Journal:  Clin Infect Dis       Date:  2000-05-18       Impact factor: 9.079

Review 7.  [Two pneumococcal vaccines: the 7-valent conjugate vaccine (Prevenar) for children up to the age of 5 years and the 23-valent polysaccharide vaccine (Pneumo 23) for the elderly and specific groups at risk].

Authors:  S C de Greeff; E A M Sanders; H E de Melker; A van der Ende; P E Vermeer; L M Schouls
Journal:  Ned Tijdschr Geneeskd       Date:  2007-06-30

8.  Seasonal variation in host susceptibility and cycles of certain infectious diseases.

Authors:  S F Dowell
Journal:  Emerg Infect Dis       Date:  2001 May-Jun       Impact factor: 6.883

9.  Seasonal patterns of invasive pneumococcal disease.

Authors:  Scott F Dowell; Cynthia G Whitney; Carolyn Wright; Charles E Rose; Anne Schuchat
Journal:  Emerg Infect Dis       Date:  2003-05       Impact factor: 6.883

10.  A role for Streptococcus pneumoniae in virus-associated pneumonia.

Authors:  Shabir A Madhi; Keith P Klugman
Journal:  Nat Med       Date:  2004-07-11       Impact factor: 53.440

View more
  45 in total

1.  Detection of excess influenza severity: associating respiratory hospitalization and mortality data with reports of influenza-like illness by primary care physicians.

Authors:  Cees C van den Wijngaard; Liselotte van Asten; Adam Meijer; Wilfrid van Pelt; Nico J D Nagelkerke; Gé A Donker; Marianne A B van der Sande; Marion P G Koopmans
Journal:  Am J Public Health       Date:  2010-09-23       Impact factor: 9.308

2.  The management of community-acquired pneumonia in infants and children older than 3 months of age: clinical practice guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America.

Authors:  John S Bradley; Carrie L Byington; Samir S Shah; Brian Alverson; Edward R Carter; Christopher Harrison; Sheldon L Kaplan; Sharon E Mace; George H McCracken; Matthew R Moore; Shawn D St Peter; Jana A Stockwell; Jack T Swanson
Journal:  Clin Infect Dis       Date:  2011-08-31       Impact factor: 9.079

3.  [The universal influenza vaccination in children with Vaxigrip Tetra® in Italy: an evaluation of Health Technology Assessment].

Authors:  Sara Boccalini; Angela Bechini; Maddalena Innocenti; Gino Sartor; Federico Manzi; Paolo Bonanni; Donatella Panatto; Piero Luigi Lai; Francesca Zangrillo; Emanuela Rizzitelli; Mariasilvia Iovine; Daniela Amicizia; Chiara Bini; Andrea Marcellusi; Francesco Saverio Mennini; Alessandro Rinaldi; Francesca Trippi; Anna Maria Ferriero; Giovanni Checcucci Lisi
Journal:  J Prev Med Hyg       Date:  2018-05-30

4.  Identifying the interaction between influenza and pneumococcal pneumonia using incidence data.

Authors:  Sourya Shrestha; Betsy Foxman; Daniel M Weinberger; Claudia Steiner; Cécile Viboud; Pejman Rohani
Journal:  Sci Transl Med       Date:  2013-06-26       Impact factor: 17.956

5.  Favorable outcome after life-threatening meningococcal disease complicating influenza A(H1N1) infection.

Authors:  S Legriel; S Merceron; P Tattevin; M-A Mouvier; S Marque-Juillet; A Le Monnier; J-P Bedos; F Bruneel
Journal:  Infection       Date:  2011-06-25       Impact factor: 3.553

6.  Pediatric complicated pneumonia and pneumococcal serotype replacement: trends in hospitalized children pre and post introduction of routine vaccination with Pneumococcal Conjugate Vaccine (PCV7).

Authors:  Thea K Chibuk; Joan L Robinson; Dawn S Hartfield
Journal:  Eur J Pediatr       Date:  2010-04-10       Impact factor: 3.183

7.  Genotypic and phenotypic characterization of carriage and invasive disease isolates of Neisseria meningitidis in Finland.

Authors:  Ulla Jounio; Annika Saukkoriipi; Holly B Bratcher; Aini Bloigu; Raija Juvonen; Sylvi Silvennoinen-Kassinen; Ari Peitso; Terttu Harju; Olli Vainio; Markku Kuusi; Martin C J Maiden; Maija Leinonen; Helena Käyhty; Maija Toropainen
Journal:  J Clin Microbiol       Date:  2011-11-30       Impact factor: 5.948

8.  Impact of the 2009 influenza pandemic on pneumococcal pneumonia hospitalizations in the United States.

Authors:  Daniel M Weinberger; Lone Simonsen; Richard Jordan; Claudia Steiner; Mark Miller; Cécile Viboud
Journal:  J Infect Dis       Date:  2011-12-07       Impact factor: 5.226

9.  The synthetic bacterial lipopeptide Pam3CSK4 modulates respiratory syncytial virus infection independent of TLR activation.

Authors:  D Tien Nguyen; Lot de Witte; Martin Ludlow; Selma Yüksel; Karl-Heinz Wiesmüller; Teunis B H Geijtenbeek; Albert D M E Osterhaus; Rik L de Swart
Journal:  PLoS Pathog       Date:  2010-08-19       Impact factor: 6.823

10.  Assessing pneumococcal meningitis association with viral respiratory infections and antibiotics: insights from statistical and mathematical models.

Authors:  Lulla Opatowski; Emmanuelle Varon; Claire Dupont; Laura Temime; Sylvie van der Werf; Laurent Gutmann; Pierre-Yves Boëlle; Laurence Watier; Didier Guillemot
Journal:  Proc Biol Sci       Date:  2013-06-19       Impact factor: 5.349

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.